FDA.reportPublic FDA data

Rubraca 300 MG Oral Tablet

RxCUI
1862590
RxNorm name
Rubraca 300 MG Oral Tablet
Display name
Rubraca 300 MG Oral Tablet
Full name
Rubraca 300 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RubracaRUCAPARIBpharmaand GmbH0295d202-1cfe-7659-e063-6294a90a476e2025-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1862590

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0295d202-1cfe-7659-e063-6294a90a476eRubraca 300 MG Oral Tablet [PSN] · rucaparib 300 MG Oral Tablet [Rubraca] [SBD] · Rubraca (as rucaparib camisylate) 300 MG Oral Tablet [SY] · Rubraca 300 MG Oral Tablet [SY]419These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA. RUBRACA ® (rucaparib) tablets, for oral use Initial U.S. Approval: 201620251231